Breast Carcinoma Tissue Array with Survival and Treatment Info
Price
$580.00
Catalogue No | TMAFC1201 |
Species | Human |
Fixative | Formalin |
Total Cases | 26 |
Total Cores | 84 |
Storage | Short term RT; Long term 4ÂșC |
Usage | For research use only. |
A | O | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B | O | O | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
C | O | O | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
D | O | O | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E | O | O | O | O | O | O | O | O | O | O | O | O | O | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F | O | O | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
G | O | O | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
H | O | O | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
N | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O |
Showing All Data
Map ID | Gender | Race | Age | Tumor Site | Histology | Grade | General Stage | TNM | Stage | ER | PR | HER2 | Laterality | Surgery Procedure | Involved | Examined | Tobacco | Alcohol | Family | First Recurrence | Age At Death | Date | Date (MM/YY) | Type | Treatment 1 | Date 1 | Source 1 | Treatment 2 | Date 2 | Source 2 | Treatment 3 | Date 3 | Source 3 | Treatment 4 | Date 4 | Source 4 | Treatment 5 | Date 5 | Source 5 | Treatment 6 | Date 6 | Source 6 | Treatment 7 | Date 7 | Source 7 | Treatment 8 | Date 8 | Source 8 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A4 | N/A | N/A | N/A | Liver | Normal (tissue marker) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
B2 | F | White | 51.6461 | Upper-inner quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T2N1M0 | -2B | + | + | + | Left - origin of primary | Code 51 w/reconstruction - Tissue | 6 | 10 | Previous Use | Current Use of Alcohol | Yes | 60 | N/A | 6/11 | 3/01 | MALIG-PRIMARY | Surgery | 6/2001 | Diagnosis | Chemotherapy | 8/2001 | Diagnosis | Radiation-0 | 3/2002 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
B3 | F | White | 51.6461 | Upper-inner quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T2N1M0 | -2B | + | + | + | Left - origin of primary | Code 51 w/reconstruction - Tissue | 6 | 10 | Previous Use | Current Use of Alcohol | Yes | 60 | N/A | 6/11 | 3/01 | MALIG-PRIMARY | Surgery | 6/2001 | Diagnosis | Chemotherapy | 8/2001 | Diagnosis | Radiation-0 | 3/2002 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
B4 | F | White | 51.6461 | Upper-inner quadrant of breast | Normal | G3 | Regional to Lymph Nodes | -T2N1M0 | -2B | + | + | + | Left - origin of primary | Code 51 w/reconstruction - Tissue | 6 | 10 | Previous Use | Current Use of Alcohol | Yes | 60 | N/A | 6/11 | 3/01 | MALIG-PRIMARY | Surgery | 6/2001 | Diagnosis | Chemotherapy | 8/2001 | Diagnosis | Radiation-0 | 3/2002 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
B5 | F | White | 51.6461 | Upper-inner quadrant of breast | Normal | G3 | Regional to Lymph Nodes | -T2N1M0 | -2B | + | + | + | Left - origin of primary | Code 51 w/reconstruction - Tissue | 6 | 10 | Previous Use | Current Use of Alcohol | Yes | 60 | N/A | 6/11 | 3/01 | MALIG-PRIMARY | Surgery | 6/2001 | Diagnosis | Chemotherapy | 8/2001 | Diagnosis | Radiation-0 | 3/2002 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
B6 | F | White | 43.7850 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T2N1bM0 | -2B | + | + | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 2 | 19 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 10/08 | 10/01 | MALIG-PRIMARY | Surgery | 1/2002 | Diagnosis | Surgery | 1/2002 | Diagnosis | Chemotherapy | 2/2002 | Diagnosis | Radiation-0 | 7/2002 | Diagnosis | Hormone Therapy | 9/2002 | Diagnosis | Hormone Therapy | 5/2004 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
B7 | F | White | 43.7850 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T2N1bM0 | -2B | + | + | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 2 | 19 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 10/08 | 10/01 | MALIG-PRIMARY | Surgery | 1/2002 | Diagnosis | Surgery | 1/2002 | Diagnosis | Chemotherapy | 2/2002 | Diagnosis | Radiation-0 | 7/2002 | Diagnosis | Hormone Therapy | 9/2002 | Diagnosis | Hormone Therapy | 5/2004 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
B8 | F | White | 43.7850 | Upper-outer quadrant of breast | Normal | G3 | Regional to Lymph Nodes | -T2N1bM0 | -2B | + | + | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 2 | 19 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 10/08 | 10/01 | MALIG-PRIMARY | Surgery | 1/2002 | Diagnosis | Surgery | 1/2002 | Diagnosis | Chemotherapy | 2/2002 | Diagnosis | Radiation-0 | 7/2002 | Diagnosis | Hormone Therapy | 9/2002 | Diagnosis | Hormone Therapy | 5/2004 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
B9 | F | White | 43.7850 | Upper-outer quadrant of breast | Normal | G3 | Regional to Lymph Nodes | -T2N1bM0 | -2B | + | + | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 2 | 19 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 10/08 | 10/01 | MALIG-PRIMARY | Surgery | 1/2002 | Diagnosis | Surgery | 1/2002 | Diagnosis | Chemotherapy | 2/2002 | Diagnosis | Radiation-0 | 7/2002 | Diagnosis | Hormone Therapy | 9/2002 | Diagnosis | Hormone Therapy | 5/2004 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
B10 | F | White | 78.4781 | Lower-inner quadrant of breast | Infiltrating duct and lobular carcinoma | G3 | Localized | -T2N0M0 | -2A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 0 | 13 | Never Used | No History of Alcohol Use | Yes | 17 | N/A | 9/04 | 1/02 | MALIG-PRIMARY | Surgery | 1/2002 | Diagnosis | Immunotherapy | 7/2003 | Follow-up | Chemotherapy | 8/2003 | Follow-up | Chemotherapy | 12/2003 | Follow-up | Chemotherapy | 12/2003 | Follow-up | Radiation | 1/2004 | Follow-up | Radiation | 4/2004 | Follow-up | Radiation | 38197 | Follow-up |
B11 | F | White | 78.4781 | Lower-inner quadrant of breast | Infiltrating duct and lobular carcinoma | G3 | Localized | -T2N0M0 | -2A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 0 | 13 | Never Used | No History of Alcohol Use | Yes | 17 | N/A | 9/04 | 1/02 | MALIG-PRIMARY | Surgery | 1/2002 | Diagnosis | Immunotherapy | 7/2003 | Follow-up | Chemotherapy | 8/2003 | Follow-up | Chemotherapy | 12/2003 | Follow-up | Chemotherapy | 12/2003 | Follow-up | Radiation | 1/2004 | Follow-up | Radiation | 4/2004 | Follow-up | Radiation | 38197 | Follow-up |
B12 | F | White | 78.4781 | Lower-inner quadrant of breast | Normal | G3 | Localized | -T2N0M0 | -2A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 0 | 13 | Never Used | No History of Alcohol Use | Yes | 17 | N/A | 9/04 | 1/02 | MALIG-PRIMARY | Surgery | 1/2002 | Diagnosis | Immunotherapy | 7/2003 | Follow-up | Chemotherapy | 8/2003 | Follow-up | Chemotherapy | 12/2003 | Follow-up | Chemotherapy | 12/2003 | Follow-up | Radiation | 1/2004 | Follow-up | Radiation | 4/2004 | Follow-up | Radiation | 38197 | Follow-up |
B13 | F | White | 78.4781 | Lower-inner quadrant of breast | Normal | G3 | Localized | -T2N0M0 | -2A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 0 | 13 | Never Used | No History of Alcohol Use | Yes | 17 | N/A | 9/04 | 1/02 | MALIG-PRIMARY | Surgery | 1/2002 | Diagnosis | Immunotherapy | 7/2003 | Follow-up | Chemotherapy | 8/2003 | Follow-up | Chemotherapy | 12/2003 | Follow-up | Chemotherapy | 12/2003 | Follow-up | Radiation | 1/2004 | Follow-up | Radiation | 4/2004 | Follow-up | Radiation | 38197 | Follow-up |
C2 | F | White | 48.855 | Upper-inner quadrant of breast | Infiltrating duct carcinoma | G3 | Localized | -T1cN0M0 | -1 | + | + | + | Right - origin of primary | Lumpectomy or excisional biopsy | 0 | 5 | Never Used | No History of Alcohol Use | No | N/A | N/A | 5/09 | 7/04 | MALIG-PRIMARY | Surgery | 8/2002 | Diagnosis | Chemotherapy | 9/2002 | Diagnosis | Hormone Therapy | 12/2002 | Diagnosis | Radiation-0 | 12/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C3 | F | White | 48.855 | Upper-inner quadrant of breast | Infiltrating duct carcinoma | G3 | Localized | -T1cN0M0 | -1 | + | + | + | Right - origin of primary | Lumpectomy or excisional biopsy | 0 | 5 | Never Used | No History of Alcohol Use | No | N/A | N/A | 5/09 | 7/04 | MALIG-PRIMARY | Surgery | 8/2002 | Diagnosis | Chemotherapy | 9/2002 | Diagnosis | Hormone Therapy | 12/2002 | Diagnosis | Radiation-0 | 12/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C4 | F | White | 48.855 | Upper-inner quadrant of breast | Normal | G3 | Localized | -T1cN0M0 | -1 | + | + | + | Right - origin of primary | Lumpectomy or excisional biopsy | 0 | 5 | Never Used | No History of Alcohol Use | No | N/A | N/A | 5/09 | 7/04 | MALIG-PRIMARY | Surgery | 8/2002 | Diagnosis | Chemotherapy | 9/2002 | Diagnosis | Hormone Therapy | 12/2002 | Diagnosis | Radiation-0 | 12/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C5 | F | White | 48.855 | Upper-inner quadrant of breast | Normal | G3 | Localized | -T1cN0M0 | -1 | + | + | + | Right - origin of primary | Lumpectomy or excisional biopsy | 0 | 5 | Never Used | No History of Alcohol Use | No | N/A | N/A | 5/09 | 7/04 | MALIG-PRIMARY | Surgery | 8/2002 | Diagnosis | Chemotherapy | 9/2002 | Diagnosis | Hormone Therapy | 12/2002 | Diagnosis | Radiation-0 | 12/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C6 | F | White | 47.1354 | Overlapping lesion of breast | Infiltrating duct carcinoma | G2 | Localized | T1cN0M0 | 1 | + | + | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 0 | 3 | Never Used | No History of Alcohol Use | No | N/A | N/A | 6/10 | 5/03 | MALIG-PRIMARY | Surgery | 6/2003 | Diagnosis | Surgery | 7/2003 | Diagnosis | Chemotherapy | 7/2003 | Diagnosis | Hormone Therapy | 9/2003 | Diagnosis | Radiation-0 | 10/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C7 | F | White | 47.1354 | Overlapping lesion of breast | Infiltrating duct carcinoma | G2 | Localized | T1cN0M0 | 1 | + | + | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 0 | 3 | Never Used | No History of Alcohol Use | No | N/A | N/A | 6/10 | 5/03 | MALIG-PRIMARY | Surgery | 6/2003 | Diagnosis | Surgery | 7/2003 | Diagnosis | Chemotherapy | 7/2003 | Diagnosis | Hormone Therapy | 9/2003 | Diagnosis | Radiation-0 | 10/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C8 | F | White | 47.1354 | Overlapping lesion of breast | Normal | G2 | Localized | T1cN0M0 | 1 | + | + | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 0 | 3 | Never Used | No History of Alcohol Use | No | N/A | N/A | 6/10 | 5/03 | MALIG-PRIMARY | Surgery | 6/2003 | Diagnosis | Surgery | 7/2003 | Diagnosis | Chemotherapy | 7/2003 | Diagnosis | Hormone Therapy | 9/2003 | Diagnosis | Radiation-0 | 10/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C9 | F | White | 47.1354 | Overlapping lesion of breast | Normal | G2 | Localized | T1cN0M0 | 1 | + | + | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 0 | 3 | Never Used | No History of Alcohol Use | No | N/A | N/A | 6/10 | 5/03 | MALIG-PRIMARY | Surgery | 6/2003 | Diagnosis | Surgery | 7/2003 | Diagnosis | Chemotherapy | 7/2003 | Diagnosis | Hormone Therapy | 9/2003 | Diagnosis | Radiation-0 | 10/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C10 | F | White | 52.859 | Lower-inner quadrant of breast | Infiltrating duct and lobular carcinoma | G3 | Regional to Lymph Nodes | T1cN0M0T1cN1aM0 | 12A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 3 | 17 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 10/10 | 10/03 | MALIG-PRIMARY | Surgery | 12/2003 | Diagnosis | Chemotherapy | 1/2004 | Diagnosis | Radiation-0 | 6/20004 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C11 | F | White | 52.859 | Lower-inner quadrant of breast | Infiltrating duct and lobular carcinoma | G3 | Regional to Lymph Nodes | T1cN0M0T1cN1aM0 | 12A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 3 | 17 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 10/10 | 10/03 | MALIG-PRIMARY | Surgery | 12/2003 | Diagnosis | Chemotherapy | 1/2004 | Diagnosis | Radiation-0 | 6/20004 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C12 | F | White | 52.859 | Lower-inner quadrant of breast | Normal | G3 | Regional to Lymph Nodes | T1cN0M0T1cN1aM0 | 12A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 3 | 17 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 10/10 | 10/03 | MALIG-PRIMARY | Surgery | 12/2003 | Diagnosis | Chemotherapy | 1/2004 | Diagnosis | Radiation-0 | 6/20004 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
C13 | F | White | 52.859 | Lower-inner quadrant of breast | Normal | G3 | Regional to Lymph Nodes | T1cN0M0T1cN1aM0 | 12A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 3 | 17 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 10/10 | 10/03 | MALIG-PRIMARY | Surgery | 12/2003 | Diagnosis | Chemotherapy | 1/2004 | Diagnosis | Radiation-0 | 6/20004 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
D2 | N/A | N/A | N/A | Liver | Normal (tissue marker) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
D3 | F | White | 24.4229 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T1N1M0T2N2aM0 | 2A3A | + | + | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 6 | 23 | Never Used | No History of Alcohol Use | Yes | 28 | 29.24 | 8/08 | 10/03 | MALIG-PRIMARY | Surgery | 12/2003 | Diagnosis | Chemotherapy | 1/2004 | Diagnosis | Radiation-0 | 6/20004 | Diagnosis | Hormone Therapy | 8/2004 | Diagnosis | Chemotherapy | 8/2005 | Follow-up | Radiation | 10/2006 | Follow-up | Chemotherapy | 10/2007 | Follow-up | N/A | N/A | N/A |
D4 | F | White | 24.4229 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T1N1M0T2N2aM0 | 2A3A | + | + | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 6 | 23 | Never Used | No History of Alcohol Use | Yes | 28 | 29.24 | 8/08 | 10/03 | MALIG-PRIMARY | Surgery | 12/2003 | Diagnosis | Chemotherapy | 1/2004 | Diagnosis | Radiation-0 | 6/20004 | Diagnosis | Hormone Therapy | 8/2004 | Diagnosis | Chemotherapy | 8/2005 | Follow-up | Radiation | 10/2006 | Follow-up | Chemotherapy | 10/2007 | Follow-up | N/A | N/A | N/A |
D5 | F | White | 24.4229 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T1N1M0T2N2aM0 | 2A3A | + | + | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 6 | 23 | Never Used | No History of Alcohol Use | Yes | 28 | 29.24 | 8/08 | 10/03 | MALIG-PRIMARY | Surgery | 12/2003 | Diagnosis | Chemotherapy | 1/2004 | Diagnosis | Radiation-0 | 6/20004 | Diagnosis | Hormone Therapy | 8/2004 | Diagnosis | Chemotherapy | 8/2005 | Follow-up | Radiation | 10/2006 | Follow-up | Chemotherapy | 10/2007 | Follow-up | N/A | N/A | N/A |
D6 | F | White | 24.4229 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T1N1M0T2N2aM0 | 2A3A | + | + | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 6 | 23 | Never Used | No History of Alcohol Use | Yes | 28 | 29.24 | 8/08 | 10/03 | MALIG-PRIMARY | Surgery | 12/2003 | Diagnosis | Chemotherapy | 1/2004 | Diagnosis | Radiation-0 | 6/20004 | Diagnosis | Hormone Therapy | 8/2004 | Diagnosis | Chemotherapy | 8/2005 | Follow-up | Radiation | 10/2006 | Follow-up | Chemotherapy | 10/2007 | Follow-up | N/A | N/A | N/A |
D7 | F | White | 38.0643 | Lower-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T1cN1aM0 | 2B2A | - | - | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 3 | 12 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 4/11 | 10/04 | MALIG-PRIMARY | Surgery | 11/2004 | Diagnosis | Chemotherapy | 1/2005 | Diagnosis | Immunotherapy | 4/2005 | Diagnosis | Radiation-0 | 8/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
D8 | F | White | 38.0643 | Lower-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T1cN1aM0 | 2B2A | - | - | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 3 | 12 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 4/11 | 10/04 | MALIG-PRIMARY | Surgery | 11/2004 | Diagnosis | Chemotherapy | 1/2005 | Diagnosis | Immunotherapy | 4/2005 | Diagnosis | Radiation-0 | 8/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
D9 | F | White | 38.0643 | Lower-outer quadrant of breast | Normal | G3 | Regional to Lymph Nodes | T2N1M0T1cN1aM0 | 2B2A | - | - | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 3 | 12 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 4/11 | 10/04 | MALIG-PRIMARY | Surgery | 11/2004 | Diagnosis | Chemotherapy | 1/2005 | Diagnosis | Immunotherapy | 4/2005 | Diagnosis | Radiation-0 | 8/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
D10 | F | White | 38.0643 | Lower-outer quadrant of breast | Normal | G3 | Regional to Lymph Nodes | T2N1M0T1cN1aM0 | 2B2A | - | - | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 3 | 12 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 4/11 | 10/04 | MALIG-PRIMARY | Surgery | 11/2004 | Diagnosis | Chemotherapy | 1/2005 | Diagnosis | Immunotherapy | 4/2005 | Diagnosis | Radiation-0 | 8/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
D11 | F | White | 39.2744 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N0M0T2N2aM0 | 2A3A | - | - | + | Left - origin of primary | Code 42 w/reconstruction - Implant | 5 | 25 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 6/11 | 9/04 | MALIG-PRIMARY | Surgery | 11/2004 | Diagnosis | Chemotherapy | 12/2004 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
D12 | F | White | 39.2744 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N0M0T2N2aM0 | 2A3A | - | - | + | Left - origin of primary | Code 42 w/reconstruction - Implant | 5 | 25 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 6/11 | 9/04 | MALIG-PRIMARY | Surgery | 11/2004 | Diagnosis | Chemotherapy | 12/2004 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
D13 | F | White | 39.2744 | Upper-outer quadrant of breast | Normal | G3 | Regional to Lymph Nodes | T2N0M0T2N2aM0 | 2A3A | - | - | + | Left - origin of primary | Code 42 w/reconstruction - Implant | 5 | 25 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 6/11 | 9/04 | MALIG-PRIMARY | Surgery | 11/2004 | Diagnosis | Chemotherapy | 12/2004 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
E1 | F | White | 39.2744 | Upper-outer quadrant of breast | Normal | G3 | Regional to Lymph Nodes | T2N0M0T2N2aM0 | 2A3A | - | - | + | Left - origin of primary | Code 42 w/reconstruction - Implant | 5 | 25 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 6/11 | 9/04 | MALIG-PRIMARY | Surgery | 11/2004 | Diagnosis | Chemotherapy | 12/2004 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
E2 | F | Black | 56.561 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T2N3M0 | 2B3C | - | N/A | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 13 | 15 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 12/04 | MALIG-PRIMARY | Surgery | 1/2005 | Diagnosis | Chemotherapy | 3/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
E3 | F | Black | 56.561 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T2N3M0 | 2B3C | - | N/A | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 13 | 15 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 12/04 | MALIG-PRIMARY | Surgery | 1/2005 | Diagnosis | Chemotherapy | 3/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
E4 | F | Black | 56.561 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T2N1M0T2N3M0 | 2B3C | - | N/A | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 13 | 15 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 12/04 | MALIG-PRIMARY | Surgery | 1/2005 | Diagnosis | Chemotherapy | 3/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
E5 | F | Black | 56.561 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T2N1M0T2N3M0 | 2B3C | - | N/A | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 13 | 15 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 12/04 | MALIG-PRIMARY | Surgery | 1/2005 | Diagnosis | Chemotherapy | 3/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
E6 | F | White | 53.6458 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T3N1M0T3N3M0 | 3A3C | - | + | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 18 | 25 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 2/05 | MALIG-PRIMARY | Surgery | 3/2005 | Diagnosis | Chemotherapy | 4/2005 | Diagnosis | Radiation-0 | 10/2005 | Diagnosis | Hormone Therapy | 3/2007 | Diagnosis | Hormone Therapy | 8/2006 | Follow-up | Hormone Therapy | 3/2007 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
E7 | F | White | 53.6458 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T3N1M0T3N3M0 | 3A3C | - | + | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 18 | 25 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 2/05 | MALIG-PRIMARY | Surgery | 3/2005 | Diagnosis | Chemotherapy | 4/2005 | Diagnosis | Radiation-0 | 10/2005 | Diagnosis | Hormone Therapy | 3/2007 | Diagnosis | Hormone Therapy | 8/2006 | Follow-up | Hormone Therapy | 3/2007 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
E8 | F | White | 53.6458 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T3N1M0T3N3M0 | 3A3C | - | + | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 18 | 25 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 2/05 | MALIG-PRIMARY | Surgery | 3/2005 | Diagnosis | Chemotherapy | 4/2005 | Diagnosis | Radiation-0 | 10/2005 | Diagnosis | Hormone Therapy | 3/2007 | Diagnosis | Hormone Therapy | 8/2006 | Follow-up | Hormone Therapy | 3/2007 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
E9 | F | White | 53.6458 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T3N1M0T3N3M0 | 3A3C | - | + | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 18 | 25 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 2/05 | MALIG-PRIMARY | Surgery | 3/2005 | Diagnosis | Chemotherapy | 4/2005 | Diagnosis | Radiation-0 | 10/2005 | Diagnosis | Hormone Therapy | 3/2007 | Diagnosis | Hormone Therapy | 8/2006 | Follow-up | Hormone Therapy | 3/2007 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
E10 | F | White | 50.6955 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G2 | Regional to Lymph Nodes | T1N0M0T2N1aM0 | 12B | + | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 1 | 25 | Cigarette Smoker, Current | No History of Alcohol Use | Yes | N/A | N/A | 8/11 | 2/05 | MALIG-PRIMARY | Surgery | 5/2005 | Diagnosis | Chemotherapy | 7/2005 | Diagnosis | Hormone Therapy | 7/2007 | Diagnosis | Chemotherapy | 10/2005 | Follow-up | Hormone Therapy | 7/2007 | Follow-up | Hormone Therapy | 11/2007 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
E11 | F | White | 50.6955 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G2 | Regional to Lymph Nodes | T1N0M0T2N1aM0 | 12B | + | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 1 | 25 | Cigarette Smoker, Current | No History of Alcohol Use | Yes | N/A | N/A | 8/11 | 2/05 | MALIG-PRIMARY | Surgery | 5/2005 | Diagnosis | Chemotherapy | 7/2005 | Diagnosis | Hormone Therapy | 7/2007 | Diagnosis | Chemotherapy | 10/2005 | Follow-up | Hormone Therapy | 7/2007 | Follow-up | Hormone Therapy | 11/2007 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
E12 | F | White | 50.6955 | Upper-outer quadrant of breast | Normal | G2 | Regional to Lymph Nodes | T1N0M0T2N1aM0 | 12B | + | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 1 | 25 | Cigarette Smoker, Current | No History of Alcohol Use | Yes | N/A | N/A | 8/11 | 2/05 | MALIG-PRIMARY | Surgery | 5/2005 | Diagnosis | Chemotherapy | 7/2005 | Diagnosis | Hormone Therapy | 7/2007 | Diagnosis | Chemotherapy | 10/2005 | Follow-up | Hormone Therapy | 7/2007 | Follow-up | Hormone Therapy | 11/2007 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
E13 | F | White | 50.6955 | Upper-outer quadrant of breast | Normal | G2 | Regional to Lymph Nodes | T1N0M0T2N1aM0 | 12B | + | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 1 | 25 | Cigarette Smoker, Current | No History of Alcohol Use | Yes | N/A | N/A | 8/11 | 2/05 | MALIG-PRIMARY | Surgery | 5/2005 | Diagnosis | Chemotherapy | 7/2005 | Diagnosis | Hormone Therapy | 7/2007 | Diagnosis | Chemotherapy | 10/2005 | Follow-up | Hormone Therapy | 7/2007 | Follow-up | Hormone Therapy | 11/2007 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A |
F2 | F | Black | 74.4279 | Central portion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T1N2M0 | -3A | - | - | + | Left - origin of primary | Code 41 w/reconstruction - Tissue | 5 | 14 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 9/10 | 3/05 | MALIG-PRIMARY | Surgery | 3/2005 | Diagnosis | Surgery | 5/2005 | Diagnosis | Chemotherapy | 7/2007 | Diagnosis | Radiation-0 | 12/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F3 | F | Black | 74.4279 | Central portion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T1N2M0 | -3A | - | - | + | Left - origin of primary | Code 41 w/reconstruction - Tissue | 5 | 14 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 9/10 | 3/05 | MALIG-PRIMARY | Surgery | 3/2005 | Diagnosis | Surgery | 5/2005 | Diagnosis | Chemotherapy | 7/2007 | Diagnosis | Radiation-0 | 12/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F4 | F | Black | 74.4279 | Central portion of breast | Normal | G3 | Regional to Lymph Nodes | -T1N2M0 | -3A | - | - | + | Left - origin of primary | Code 41 w/reconstruction - Tissue | 5 | 14 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 9/10 | 3/05 | MALIG-PRIMARY | Surgery | 3/2005 | Diagnosis | Surgery | 5/2005 | Diagnosis | Chemotherapy | 7/2007 | Diagnosis | Radiation-0 | 12/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F5 | F | Black | 74.4279 | Central portion of breast | Normal | G3 | Regional to Lymph Nodes | -T1N2M0 | -3A | - | - | + | Left - origin of primary | Code 41 w/reconstruction - Tissue | 5 | 14 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 9/10 | 3/05 | MALIG-PRIMARY | Surgery | 3/2005 | Diagnosis | Surgery | 5/2005 | Diagnosis | Chemotherapy | 7/2007 | Diagnosis | Radiation-0 | 12/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F6 | F | White | 49.2253 | Overlapping lesion of breast | Infiltrating duct and lobular carcinoma | G3 | Regional to Lymph Nodes | T2N0M0T3N2aM0 | 2A3A | - | - | - | Left - origin of primary | Code 41 w/reconstruction - Tissue | 4 | 19 | Never Used | No History of Alcohol Use | Yes | 36 | 53.03 | 1/09 | 3/05 | MALIG-PRIMARY | Surgery | 6/2005 | Diagnosis | Chemotherapy | 7/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F7 | F | White | 49.2253 | Overlapping lesion of breast | Infiltrating duct and lobular carcinoma | G3 | Regional to Lymph Nodes | T2N0M0T3N2aM0 | 2A3A | - | - | - | Left - origin of primary | Code 41 w/reconstruction - Tissue | 4 | 19 | Never Used | No History of Alcohol Use | Yes | 36 | 53.03 | 1/09 | 3/05 | MALIG-PRIMARY | Surgery | 6/2005 | Diagnosis | Chemotherapy | 7/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F8 | F | White | 49.2253 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T2N0M0T3N2aM0 | 2A3A | - | - | - | Left - origin of primary | Code 41 w/reconstruction - Tissue | 4 | 19 | Never Used | No History of Alcohol Use | Yes | 36 | 53.03 | 1/09 | 3/05 | MALIG-PRIMARY | Surgery | 6/2005 | Diagnosis | Chemotherapy | 7/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F9 | F | White | 49.2253 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T2N0M0T3N2aM0 | 2A3A | - | - | - | Left - origin of primary | Code 41 w/reconstruction - Tissue | 4 | 19 | Never Used | No History of Alcohol Use | Yes | 36 | 53.03 | 1/09 | 3/05 | MALIG-PRIMARY | Surgery | 6/2005 | Diagnosis | Chemotherapy | 7/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F10 | F | White | 44.4950 | Upper-inner quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T3N0M0T2N1M0 | 2B | - | - | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 1 | 13 | Previous Use | No History of Alcohol Use | No | N/A | N/A | 5/11 | 5/05 | MALIG-PRIMARY | Surgery | 6/2005 | Diagnosis | Chemotherapy | 8/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F11 | F | White | 44.4950 | Upper-inner quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T3N0M0T2N1M0 | 2B | - | - | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 1 | 13 | Previous Use | No History of Alcohol Use | No | N/A | N/A | 5/11 | 5/05 | MALIG-PRIMARY | Surgery | 6/2005 | Diagnosis | Chemotherapy | 8/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F12 | F | White | 44.4950 | Upper-inner quadrant of breast | Normal | G3 | Regional to Lymph Nodes | T3N0M0T2N1M0 | 2B | - | - | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 1 | 13 | Previous Use | No History of Alcohol Use | No | N/A | N/A | 5/11 | 5/05 | MALIG-PRIMARY | Surgery | 6/2005 | Diagnosis | Chemotherapy | 8/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
F13 | F | White | 44.4950 | Upper-inner quadrant of breast | Normal | G3 | Regional to Lymph Nodes | T3N0M0T2N1M0 | 2B | - | - | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 1 | 13 | Previous Use | No History of Alcohol Use | No | N/A | N/A | 5/11 | 5/05 | MALIG-PRIMARY | Surgery | 6/2005 | Diagnosis | Chemotherapy | 8/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G2 | F | White | 42.0844 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N0M0T2N2M0 | 2A3A | + | + | + | Left - origin of primary | Code 51 w/reconstruction - Tissue | 5 | 21 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 8/07 | MALIG-PRIMARY | Surgery | 11/2007 | Diagnosis | Chemotherapy | 12/2007 | Diagnosis | Radiation-0 | 6/2008 | Diagnosis | Hormone Therapy | 6/2008 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G3 | F | White | 42.0844 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N0M0T2N2M0 | 2A3A | + | + | + | Left - origin of primary | Code 51 w/reconstruction - Tissue | 5 | 21 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 8/07 | MALIG-PRIMARY | Surgery | 11/2007 | Diagnosis | Chemotherapy | 12/2007 | Diagnosis | Radiation-0 | 6/2008 | Diagnosis | Hormone Therapy | 6/2008 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G4 | F | White | 42.0844 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T2N0M0T2N2M0 | 2A3A | + | + | + | Left - origin of primary | Code 51 w/reconstruction - Tissue | 5 | 21 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 8/07 | MALIG-PRIMARY | Surgery | 11/2007 | Diagnosis | Chemotherapy | 12/2007 | Diagnosis | Radiation-0 | 6/2008 | Diagnosis | Hormone Therapy | 6/2008 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G5 | F | White | 42.0844 | Overlapping lesion of breast | Normal | G3 | Regional to Lymph Nodes | T2N0M0T2N2M0 | 2A3A | + | + | + | Left - origin of primary | Code 51 w/reconstruction - Tissue | 5 | 21 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 8/07 | MALIG-PRIMARY | Surgery | 11/2007 | Diagnosis | Chemotherapy | 12/2007 | Diagnosis | Radiation-0 | 6/2008 | Diagnosis | Hormone Therapy | 6/2008 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G6 | F | White | 47.0557 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T2N1bM0 | -2B | - | - | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 1 | 12 | Never Used | No History of Alcohol Use | Yes | 9 | N/A | 8/11 | 12/00 | MALIG-PRIMARY | Surgery | 2/2001 | Diagnosis | Surgery | 2/2001 | Diagnosis | Chemotherapy | 3/2001 | Diagnosis | Surgery | 10/2001 | Follow-up | Chemotherapy | 11/2001 | Follow-up | Immunotherapy | 11/2001 | Follow-up | Radiation | 3/2002 | Follow-up | N/A | N/A | N/A |
G7 | F | White | 47.0557 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T2N1bM0 | -2B | - | - | + | Right - origin of primary | Reexc of the biopsy site for gross/micro residual disease | 1 | 12 | Never Used | No History of Alcohol Use | Yes | 9 | N/A | 8/11 | 12/00 | MALIG-PRIMARY | Surgery | 2/2001 | Diagnosis | Surgery | 2/2001 | Diagnosis | Chemotherapy | 3/2001 | Diagnosis | Surgery | 10/2001 | Follow-up | Chemotherapy | 11/2001 | Follow-up | Immunotherapy | 11/2001 | Follow-up | Radiation | 3/2002 | Follow-up | N/A | N/A | N/A |
G8 | F | White | 63.4473 | Central portion of breast | Infiltrating duct and lobular carcinoma | - | Regional to Lymph Nodes | -T3N1M0 | -3A | + | + | - | Left - origin of primary | Code 51 w/reconstruction - Implant | 2 | 14 | Cigarette Smoker, Current | Current Use of Alcohol | Yes | 102 | N/A | 8/11 | 3/01 | MALIG-PRIMARY | Surgery | 5/2001 | Diagnosis | Chemotherapy | 6/2001 | Diagnosis | Radiation-0 | 1/2002 | Diagnosis | Hormone Therapy | 3/2002 | Diagnosis | Hormone Therapy | 6/2006 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G9 | F | White | 63.4473 | Central portion of breast | Infiltrating duct and lobular carcinoma | - | Regional to Lymph Nodes | -T3N1M0 | -3A | + | + | - | Left - origin of primary | Code 51 w/reconstruction - Implant | 2 | 14 | Cigarette Smoker, Current | Current Use of Alcohol | Yes | 102 | N/A | 8/11 | 3/01 | MALIG-PRIMARY | Surgery | 5/2001 | Diagnosis | Chemotherapy | 6/2001 | Diagnosis | Radiation-0 | 1/2002 | Diagnosis | Hormone Therapy | 3/2002 | Diagnosis | Hormone Therapy | 6/2006 | Follow-up | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G10 | F | Black | 46.1950 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T2N1bM0 | -2B | - | - | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 4 | 20 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 1/07 | 10/02 | MALIG-PRIMARY | Surgery | 11/2002 | Diagnosis | Chemotherapy | 1/2003 | Diagnosis | Hormone Therapy | 2/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G11 | F | Black | 46.1950 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | -T2N1bM0 | -2B | - | - | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 4 | 20 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 1/07 | 10/02 | MALIG-PRIMARY | Surgery | 11/2002 | Diagnosis | Chemotherapy | 1/2003 | Diagnosis | Hormone Therapy | 2/2003 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G12 | F | Black | 59.6965 | Central portion of breast | Infiltrating duct mixed with other types of carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T1cN3aM0 | 2B3C | + | - | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 10 | 20 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 8/09 | 3/04 | MALIG-PRIMARY | Surgery | 4/2004 | Diagnosis | Chemotherapy | 8/2004 | Diagnosis | Hormone Therapy | 4/2005 | Diagnosis | Radiation-0 | 1/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
G13 | F | Black | 59.6965 | Central portion of breast | Infiltrating duct mixed with other types of carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T1cN3aM0 | 2B3C | + | - | + | Right - origin of primary | MRM w/out removal of uninvolved contralateral breast | 10 | 20 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 8/09 | 3/04 | MALIG-PRIMARY | Surgery | 7/2004 | Diagnosis | Chemotherapy | 8/2004 | Diagnosis | Hormone Therapy | 4/2005 | Diagnosis | Radiation-0 | 1/2005 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H2 | F | White | 83.3588 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G2 | Regional to Lymph Nodes | T2N1M0T2N2aM0 | 2B3A | + | - | + | Left - origin of primary | Total mastectomy w/out removal uninvolved contralateral breast | 4 | 15 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 4/10 | 6/05 | MALIG-PRIMARY | Surgery | 8/2005 | Diagnosis | Chemotherapy | 9/2005 | Diagnosis | Radiation-0 | 5/2006 | Diagnosis | Hormone Therapy | 6/2006 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H3 | F | White | 83.3588 | Upper-outer quadrant of breast | Infiltrating duct carcinoma | G2 | Regional to Lymph Nodes | T2N1M0T2N2aM0 | 2B3A | + | - | + | Left - origin of primary | Total mastectomy w/out removal uninvolved contralateral breast | 4 | 15 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 4/10 | 6/05 | MALIG-PRIMARY | Surgery | 8/2005 | Diagnosis | Chemotherapy | 9/2005 | Diagnosis | Radiation-0 | 5/2006 | Diagnosis | Hormone Therapy | 6/2006 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H4 | F | White | 71.5877 | Central portion of breast | Infiltrating duct and lobular carcinoma | G3 | Regional to Both Direct Extension and Lymph Nodes | T2N1M0T2N2aM0 | 2B3A | + | + | + | Left - origin of primary | MRM with removal of uninvolved contralateral breast | 4 | 10 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 4/11 | 8/05 | MALIG-PRIMARY | Surgery | 9/2005 | Diagnosis | Chemotherapy | 11/2005 | Diagnosis | Radiation-0 | 5/2006 | Diagnosis | Hormone Therapy | 8/2006 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H5 | F | White | 71.5877 | Central portion of breast | Infiltrating duct and lobular carcinoma | G3 | Regional to Both Direct Extension and Lymph Nodes | T2N1M0T2N2aM0 | 2B3A | + | + | + | Left - origin of primary | MRM with removal of uninvolved contralateral breast | 4 | 10 | Previous Use | No History of Alcohol Use | Yes | N/A | N/A | 4/11 | 8/05 | MALIG-PRIMARY | Surgery | 9/2005 | Diagnosis | Chemotherapy | 11/2005 | Diagnosis | Radiation-0 | 5/2006 | Diagnosis | Hormone Therapy | 8/2006 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H6 | F | White | 39.343 | Lower-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Localized | T2N0M0 | 2A | + | + | + | Left - origin of primary | Partial mastectomy, NOS; less than total mastectomy, NOS | 0 | 2 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 8/05 | MALIG-PRIMARY | Surgery | 9/2005 | Diagnosis | Chemotherapy | 11/2005 | Diagnosis | Radiation-0 | 5/2006 | Diagnosis | Hormone Therapy | 7/2006 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H7 | F | White | 39.343 | Lower-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Localized | T2N0M0 | 2A | + | + | + | Left - origin of primary | Partial mastectomy, NOS; less than total mastectomy, NOS | 0 | 2 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 3/10 | 8/05 | MALIG-PRIMARY | Surgery | 9/2005 | Diagnosis | Chemotherapy | 11/2005 | Diagnosis | Radiation-0 | 5/2006 | Diagnosis | Hormone Therapy | 7/2006 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H8 | F | White | 66.871 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T2N3aM0 | 2B3C | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 10 | 12 | Never Used | No History of Alcohol Use | No | N/A | N/A | 6/10 | 9/05 | MALIG-PRIMARY | Surgery | 11/2005 | Diagnosis | Surgery | 2/2006 | Diagnosis | Chemotherapy | 2/2006 | Diagnosis | Radiation-0 | 9/2006 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H9 | F | White | 66.871 | Overlapping lesion of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T2N3aM0 | 2B3C | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 10 | 12 | Never Used | No History of Alcohol Use | No | N/A | N/A | 6/10 | 9/05 | MALIG-PRIMARY | Surgery | 11/2005 | Diagnosis | Surgery | 2/2006 | Diagnosis | Chemotherapy | 2/2006 | Diagnosis | Radiation-0 | 9/2006 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H10 | F | White | 71.1674 | Lower-inner quadrant of breast | Paget's disease and infiltrating duct carcinoma of breast | G3 | Regional to Lymph Nodes | T3N1M0T2N2aM0 | 3A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 4 | 15 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 10/10 | 9/07 | MALIG-PRIMARY | Surgery | 10/2007 | Diagnosis | Chemotherapy | 11/2007 | Diagnosis | Radiation-0 | 4/2008 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H11 | F | White | 71.1674 | Lower-inner quadrant of breast | Paget's disease and infiltrating duct carcinoma of breast | G3 | Regional to Lymph Nodes | T3N1M0T2N2aM0 | 3A | - | - | + | Left - origin of primary | MRM w/out removal of uninvolved contralateral breast | 4 | 15 | Never Used | No History of Alcohol Use | Yes | N/A | N/A | 10/10 | 9/07 | MALIG-PRIMARY | Surgery | 10/2007 | Diagnosis | Chemotherapy | 11/2007 | Diagnosis | Radiation-0 | 4/2008 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H12 | F | White | 56.2658 | Lower-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T2N3bM0 | 2B3C | - | - | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 12 | 29 | Previous Use | Current Use of Alcohol | Yes | N/A | N/A | 7/10 | 12/07 | MALIG-PRIMARY | Surgery | 4/2008 | Diagnosis | Chemotherapy | 5/2008 | Diagnosis | Radiation-0 | 12/2008 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
H13 | F | White | 56.2658 | Lower-outer quadrant of breast | Infiltrating duct carcinoma | G3 | Regional to Lymph Nodes | T2N1M0T2N3bM0 | 2B3C | - | - | + | Right - origin of primary | Code 51 w/reconstruction - Tissue | 12 | 29 | Previous Use | Current Use of Alcohol | Yes | N/A | N/A | 7/10 | 12/07 | MALIG-PRIMARY | Surgery | 4/2008 | Diagnosis | Chemotherapy | 5/2008 | Diagnosis | Radiation-0 | 12/2008 | Diagnosis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |